Literature DB >> 10805605

Opiate withdrawal-induced place aversion lasts for up to 16 weeks.

L Stinus1, S Caille, G F Koob.   

Abstract

RATIONALE: Administration of low doses of opiate antagonists to morphine-dependent rats produces an aversive response as measured by a conditioned place aversion, but the time course of such a learned aversion is largely unknown.
OBJECTIVES: The purpose of this experiment was to examine the time course for the expression of a place aversion to opiate withdrawal.
METHODS: Morphine-dependent rats were tested in a three-chamber place-aversion apparatus. The conditioning phase consisted of three pairings of either naloxone (15 microg/kg s.c.) or vehicle with two compartments, with the most similar time allotments during the preconditioning test. During the testing phase, rats were again allowed to explore the entire apparatus. Different groups were tested at 24 h, 1 week, 2 weeks, 4 weeks, 8 weeks, and 16 weeks post-conditioning (morphine-free tests).
RESULTS: A robust place aversion was recorded at every time point tested, including at 16 weeks. In previously published work, placebo-pelleted rats tested with naloxone at the same dose failed to show a place aversion and nondependent rats showed a stable lack of aversion at tests up to 56 days. Dependent animals without naloxone also failed to show a place aversion at any of those time points.
CONCLUSIONS: In the absence of any active intervention, the place aversion produced by opiate withdrawal is very long lasting and provides a model for protracted abstinence that may be useful for delineating the neurobiological substrate for vulnerability to relapse.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805605     DOI: 10.1007/s002139900358

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

2.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

Review 3.  Sex Differences in Animal Models: Focus on Addiction.

Authors:  Jill B Becker; George F Koob
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 4.  The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence.

Authors:  Michael J Glass
Journal:  Vitam Horm       Date:  2010       Impact factor: 3.421

5.  Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction.

Authors:  Karyn M Myers; William A Carlezon
Journal:  Neurosci Biobehav Rev       Date:  2010-01-28       Impact factor: 8.989

6.  Glucocorticoid Homeostasis in the Dentate Gyrus Is Essential for Opiate Withdrawal-Associated Memories.

Authors:  Daniel García-Pérez; Szilamer Ferenczi; Krisztina J Kovács; M Luisa Laorden; M Victoria Milanés; Cristina Núñez
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

7.  Extinction of conditioned opiate withdrawal in rats in a two-chambered place conditioning apparatus.

Authors:  Karyn M Myers; Anita J Bechtholt-Gompf; Brian R Coleman; William A Carlezon
Journal:  Nat Protoc       Date:  2012-02-23       Impact factor: 13.491

8.  Craving, context and the cortex.

Authors:  Olivier George; George F Koob
Journal:  Nat Neurosci       Date:  2011-04       Impact factor: 24.884

Review 9.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

10.  Inflated reward value in early opiate withdrawal.

Authors:  Kate M Wassum; Venuz Y Greenfield; Kay E Linker; Nigel T Maidment; Sean B Ostlund
Journal:  Addict Biol       Date:  2014-07-31       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.